[The signaling mechanism of glucocorticoid-induced T-cell apoptosis]

Taijiro Okabe1, Ryouichi Takayanagi, Toshihiko Yanase

  • 1Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University.

Insights

Glucocorticoid resistance in T-cells may be overcome by targeting extracellular signal-regulated protein kinase (ERK). This kinase inhibits programmed cell death, offering potential therapeutic strategies for glucocorticoid-resistant conditions.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Context:

  • Glucocorticoids are widely used to treat inflammatory and autoimmune diseases.
  • Glucocorticoid-induced T-cell apoptosis is a key mechanism of action.
  • Understanding the molecular pathways regulating this process is crucial for improving therapeutic efficacy.

Purpose:

  • To investigate the role of extracellular signal-regulated protein kinase (ERK) in glucocorticoid-induced T-cell apoptosis.
  • To identify potential molecular targets for overcoming glucocorticoid resistance.

Summary:

  • Glucocorticoid-induced T-cell apoptosis is generally believed to involve alterations in gene expression, with increased proapoptotic or decreased antiapoptotic gene activity.
  • However, the specific target genes remain unidentified.
  • Recent findings indicate that extracellular signal-regulated protein kinase (ERK) actively inhibits glucocorticoid-induced T-cell apoptosis.

Impact:

  • The identification of ERK as an inhibitor of glucocorticoid-induced T-cell apoptosis provides a novel target.
  • This discovery may lead to the development of new therapeutic strategies to overcome glucocorticoid resistance in T-cell mediated diseases.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...